Preferential Rights Issue / Företrädesemission 2015

Alzinova carried out a preferential rights issue of SEK 16.7 million before costs, to finance the pre-clinical development program of ALZ-101. Below you will find information in regards to this issue and the prospectus.

• Read the full prospectus
• Press release 1 Oct. 2015, publication prospectus / offentliggörande prospekt
• Press release 27 Oct. 2015, outcome of rights issue / utfall av företrädesemission